Lakewood-Amedex Biotherapeutics, Inc. (NasdaqCM: LABT)
Health Care · Biotechnology · US
$0.58
-25.85% today · -99.3% 1Y
Lakewood-Amedex Biotherapeutics, Inc. (NasdaqCM: LABT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.37M and employs 5 people.
Over the last twelve months the share price has lost 99.3%, trading between 0.58 and 98.20.
Tweenvest scores Lakewood-Amedex Biotherapeutics, Inc. across four factors: quality 44/100, value 58/100. Its strongest factor is value.
LABT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.37M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -10.20
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $98.20
- 52-week low
- $0.58
- Avg volume (3M)
- —
- Shares outstanding
- 2.37M
- Employees
- 5
- Next earnings
- —
About Lakewood-Amedex Biotherapeutics, Inc.
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
- ISIN
- US51255A2015
- Founded
- 2006
- Listed since
- Apr 23, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genprex, Inc.NasdaqCM: GNPX | $1.62M | $1.98 | -3.41% |
| BioSenic S.A.ENXTBR: BIOS | $1.47M | €0.00 | -9.09% |
| Hexima LimitedASX: HXL | $1.44M | AU$— | — |
| NKGen Biotech, Inc.OTCPK: NKGN | $1.44M | $0.01 | -0.90% |
| Protagenic Therapeutics, Inc.OTCPK: PTIX | $1.36M | $0.75 | -2.60% |
| Premier Biomedical, Inc.OTCPK: BIEI | $1.25M | $0.00 | +5.71% |
| AXIM Biotechnologies, Inc.OTCPK: AXIM | $1.23M | $0.00 | -1.31% |
| Bone Biologics CorporationNasdaqCM: BBLG | $1.09M | $0.40 | -15.44% |
Figures last refreshed Oct 18, 2026.